A Study of HRS-4729 Injection and HRS9531 Injection in Participants With Metabolic Dysfunction-Associated Steatohepatitis

NCT07660848 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Interventions

DRUG: HRS-4729 Injection
DRUG: HRS9531 Injection
DRUG: HRS-4729 Injection Placebo
DRUG: HRS9531 Injection Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.